血清CA125、CEA和HE4联检对PMPOS的诊断价值
摘要
目的:探讨血清抗原125(CA125)、CEA和HE4联检在绝经后卵巢可及综合征(PMPOS)中的检测意义。方法:采用电化学发光法测定80例PMPOS病例及40例正常人血清,其中PMPOS病例中良性卵巢肿瘤50例、恶性卵巢肿瘤30例。结果:PMPOS恶性卵巢肿瘤与良性卵巢肿瘤和对照组相比,三项标志物的血清含量有显著差异(P<0.01)。血清CA125、CEA和HE4联检的敏感性、特异性、阴性预测值、准确率均高于各单项检测值(P<0.01)。结论:血清CA125、CEA和HE4联检对PMPOS恶性卵巢肿瘤的临床诊断具有一定的应用价值。
出处
《内蒙古中医药》
2013年第35期11-12,共2页
Inner Mongolia Journal of Traditional Chinese Medicine
参考文献3
-
1唐军,孙洪莲,耿京,吕君,高淑华.经阴道超声探测绝经后卵巢可及综合征的价值[J].中国妇产科临床杂志,2004,5(5):339-342. 被引量：3
-
2Rustin GJ,Bast RC Jr,Kelloff CJ. Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer[J].{H}Clinical Cancer Research,2004.3919-3926.
-
3何江,周颖,张阳,周郁,郭勇,王泳胜,余伍忠,仇东辉.血清TSGF、CA125与CEA联合测定对卵巢癌的早期诊断价值[J].标记免疫分析与临床,2005,12(4):220-222. 被引量：1
二级参考文献15
-
1[1]Pavlik EJ,Depriest PD,Gallion H,et al.Ovarianvolume related to age'.Gynecologic Oncology,2000,77:410-412.
-
2[2]Goldstein SR.Conservative management of small postmenopausal cystic masses.Clin Obstet Gynecol,1993,36:395-400.
-
3[4]Feuer GA,Shevchuk M,Calsnog A.Normal size ovary carcinoma syndrome'.Obstet Gynecol,1989,73:786-792.
-
4[6]Roman LD,RLI,Stem SM,et al.Pelvic examination tumor marker lever and gray-scale and Doppler sonography in the prediction of pelvic cancer.Obstet Gynecol,1997,89:493-500.
-
5[7]Strigini FA,Gadducci A,Bravo BD,et al.Differential diagnosis of alnexal masses with transvaginalsonography color flow imagingand secrum CA125 assay in pre-and postmenopausal women.Gynecol Oncol,1996,61:68-72.
-
6[8]Schutter EMJ,Kenemans P,Sohn C,et al.Diagnostic value of pelvic examination Ultrasound and CA125 in postmenopausal women with a pelvic masses.Cancer,1994,74:1398-1405.
-
7[9]Maggino T,Gadducci A,D‘Addario V,et al.Prospective multicenter stady on CA125 in postmanopausal pelvic masses.Gynecol Oncol,1994,54:117-123.
-
8Meyer T,Rustin G J S. Role of tumour markers in monitoring epithelial overian cancer[J]. Brit J Cancer, 2000,82 (9) : 1535-1538.
-
9Gadducci A, Ferdeghini M, Prontera C, et al. The concomitant determination of different tumour markers in patients with epithelial ovarian cancer and benign ovarian masses:relevance for differential diagnosis[J]. Gynecologic Oncology,1992,44:147-149.
-
10李蔚范,张勇,钱和年,成宁海.绝经后妇女卵巢可及综合征[J].北京医科大学学报,1997,29(3):257-259. 被引量：8
-
1黄西元,石玉玲,张速林.联合检测HE4、CA125和CA199对绝经后卵巢可及综合征的诊断价值[J].生物技术通讯,2016,27(1):118-120.
-
2吴萍,叶伟民,李晨,夏晓红,张振成,赵文静,崔艳芳,张彩英,仲人前,杨再兴.人附睾蛋白4对慢性肾脏疾病的诊断价值研究[J].检验医学,2015,30(5):461-464. 被引量：7
-
3王莲,吴家友,杨梅花,钟美容.彩色多普勒超声在卵巢肿瘤中的应用价值[J].齐齐哈尔医学院学报,2013,34(5):706-707. 被引量：7
-
4栾建秋,寿维荣.浅谈18例良性卵巢肿瘤切除术的心理护理[J].中华医学写作杂志,2001,8(12):1440-1440.
-
5刘振美.腹腔镜手术治疗良性卵巢肿瘤护理体会[J].齐鲁护理杂志,2005,11(4):350-351. 被引量：10
-
6宋斌斌,潘柏申.卵巢癌血清标志物的临床应用[J].检验医学,2015,30(8):866-870. 被引量：11
-
7贾桂风,柴薇,门海涛,许洁,温岩.卵巢良、恶性肿瘤的超声诊断[J].中国妇幼保健,2012,27(11):1733-1735.
-
8李秀荣,宋慧,杨华.妇科肿瘤应用化疗不良反应的护理体会[J].沈阳部队医药,1996,9(4):352-352.
-
9马永红,杨丽春.超声诊断及肿瘤标志物在诊断卵巢肿瘤中的应用[J].云南医药,2008,29(4):381-386.
-
10胡秀春,齐晓慧.恶性卵巢肿瘤化学治疗的护理对策[J].现代中西医结合杂志,2001,10(14):1388-1388. 被引量：1
